Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
Adrenal gland dysfunction in males with cluster headache.
Adiponectin Fortifies White Matter After Chronic Hypoperfusion-Induced Vascular Dementia.
Correction: Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis.
Compressive Optic Neuropathy Due to Dolichoectatic Ophthalmic Artery.
Chronic Anemia Patients Demonstrate Diffuse Demyelination.
Video Head Impulse Testing in Relapsing Remitting Multiple Sclerosis: Evaluation of Canal Gains, Asymmetry, and Corrective Saccades with Cerebellar Lesions.
The correlation between serum markers of oxidative stress and fatigue and related factors in minimally disabled patients with relapsing-remitting multiple sclerosis.
Neurogenic Lower Urinary Tract Dysfunction in Women With Multiple Sclerosis.
1,3,4 oxadiazole derivative attenuates neurotransmitter-mediated inflammatory response in EAE model of multiple sclerosis.
A Comparative Readability Analysis of Artificial Intelligence-Generated and Evidence-based Medical Content on the Diagnosis and Management of Multiple Sclerosis.
Endothelial cell-secreted SPARC suppresses astrocytic CD59 expression and promotes astrocytopathy in a mouse model of neuromyelitis optica spectrum disorders.
Clinical, Electrophysiological, and Neuropathological Features of Peripheral Neuropathies in People With T-Cell Lymphoproliferative Disorder.
MicroRNA-29 acutely regulates memory stability, expression of synaptic genes, and DNA methylation in the mouse adult hippocampus.
A tailored cognitive behavioural therapy intervention for depression in those newly diagnosed with multiple sclerosis (ACTION-MS): A randomised, assessor-blinded, active comparator trial.
Oligodendrocyte dysfunction contributes to motor deficits and Purkinje cell axonopathy in spinocerebellar ataxia type 1.
ASSESSING DISABILITY LEVEL AND FATIGUE IN MULTIPLE SCLEROSIS WITH SMART SOCK SENSOR TECHNOLOGY.
PLP1 homeostatically regulates Schwann and endothelial cell function and communication in peripheral nerve repair.
Indole-3-Carbinol (I3C) suppression of IgG2b-triggered signaling in innate cells involves early suppression of p-Akt.
Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
A CSF disease-associated macrophage signature defines progressive multiple sclerosis.
Encephalitis.
Investigations of remibrutinib in models pertinent to multiple sclerosis.
Serum neurofilament light chain and multiple sclerosis prognosis: a systematic review and meta-analysis.
Chimeric antigen receptor T-cell therapy in neurological disorders: Emerging applications, evidence, and challenges.
Pages
« first
‹ previous
…
832
833
834
835
836
837
838
839
840
next ›
last »